Clinical Trials in Tennessee

Showing 9641-9660 of 15,329 trials

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

NCT02574663

This is a Phase 1 multi-center study to assess the safety and efficacy of TGR-1202 as a single agent or in combination with nab-paclitaxel + gemcitabine or with FOLFOX in patients with select relapsed or refractory solid tumors.

Pancreatic CancerColorectal CancerRectal Cancer+3 more

TG Therapeutics, Inc.66 participantsStarted Sep 2015

Nashville, Tennessee, United States

COMPLETEDPhase 329 miles

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

NCT01827046

A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).

Intracerebral Hemorrhage

Johns Hopkins University499 participantsStarted Dec 2013

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +81 more locations

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Find Trials by Condition in Tennessee

Contrast-enhanced Ultrasound of the Kidney

TGR-1202, a PI3K Delta Inhibitor, in Combination With Obinutuzumab and Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

A Study in Advanced Solid Tumors

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma